Related Experiment Video

Updated: May 31, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance

Colin D White1, Zhigang Li, Deborah A Dillon

  • 1Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA. cdwhite@bidmc.harvard.edu

The Journal of Biological Chemistry
|July 5, 2011
PubMed

Insights

IQGAP1 is overexpressed in HER2-positive breast cancer and promotes tumor growth. Reducing IQGAP1 may overcome trastuzumab resistance, offering a new treatment strategy for HER2(+) breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20-25% of breast cancers, correlating with poor prognosis.
  • Trastuzumab is a standard treatment for HER2-positive breast cancer, but intrinsic or acquired resistance limits its efficacy.
  • Understanding resistance mechanisms is crucial for improving patient survival.

Purpose of the Study:

  • To investigate the role of IQGAP1 in HER2-positive breast cancer.
  • To determine if IQGAP1 contributes to trastuzumab resistance.
  • To explore IQGAP1 inhibition as a therapeutic strategy.

Main Methods:

  • Analysis of IQGAP1 expression in HER2-positive breast cancer tissues.
  • Assessment of IQGAP1 binding to HER2.
  • Knockdown of IQGAP1 and evaluation of its effects on HER2 signaling, proliferation, and p27 expression.
  • Testing the impact of IQGAP1 reduction on trastuzumab sensitivity in resistant cells.

Main Results:

  • IQGAP1 is overexpressed in HER2-positive breast cancer and directly binds to HER2.
  • IQGAP1 knockdown reduces HER2 expression, phosphorylation, signaling, and proliferation.
  • IQGAP1 knockdown up-regulates p27, contributing to growth inhibition.
  • Reduced IQGAP1 restores trastuzumab sensitivity in resistant breast cancer cells.

Conclusions:

  • IQGAP1 plays a significant role in HER2 signaling and proliferation in breast cancer.
  • IQGAP1 overexpression is associated with trastuzumab resistance.
  • Inhibiting IQGAP1 may be a viable strategy to enhance trastuzumab efficacy in HER2-positive breast cancer.

More Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide11:02

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide

Published on: October 18, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...